IBEX TECHNOLOGIES INC. — Investor Relations & Filings
Filings indexed
122
across all filing types
Latest filing
2024-05-24
Regulatory Filings
Country
CA
Canada
Listing
TSXV
IBT
IBEX Technologies Inc. develops, manufactures, and markets high-purity enzymes and specialized reagents for biomedical use. The company's product portfolio includes a family of proprietary enzymes utilized in pharmaceutical research, notably for applications in arthritis and oncology, and diagnostic products. IBEX serves the In Vitro Diagnostics (IVD) sector and general research markets by supplying essential raw materials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Decision Document / Order for Application - French.pdf | 2024-05-24 | English | |
| Material change report - English.pdf | 2024-04-08 | English | |
| News release - English.pdf | 2024-04-08 | English | |
| News release - English.pdf | 2024-04-08 | English | |
| Material change report - English.pdf | 2024-04-03 | English | |
| News release - English.pdf | 2024-04-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 30148826 | Decision Document / Order for Application - French.pdf | 2024-05-24 | English | ||
| 29760856 | Material change report - English.pdf | 2024-04-08 | English | ||
| 29760993 | News release - English.pdf | 2024-04-08 | English | ||
| 29760953 | News release - English.pdf | 2024-04-08 | English | ||
| 13730488 | Material change report - English.pdf | 2024-04-03 | English | ||
| 13730501 | News release - English.pdf | 2024-04-03 | English | ||
| 13727927 | Material document(s).pdf | 2024-03-14 | English | ||
| 13727926 | Material document(s).pdf | 2024-03-14 | English | ||
| 13727924 | Material document(s).pdf | 2024-03-14 | English | ||
| 13728244 | News release - English.pdf | 2024-03-14 | English | ||
| 13726819 | Management information circular (amended) - English.pdf | 2024-03-13 | English | ||
| 13721729 | News release - English.pdf | 2024-02-23 | English | ||
| 13721825 | Form of proxy - English.pdf | 2024-02-23 | English | ||
| 13721823 | Other.pdf | 2024-02-23 | English | ||
| 13721822 | Other.pdf | 2024-02-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
|
CG Oncology, Inc.
Develops bladder-sparing oncolytic immunotherapies for urol…
|
CGON | US | Manufacturing |
IBEX TECHNOLOGIES INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/42661/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=42661 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=42661 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=42661 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 42661}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IBEX TECHNOLOGIES INC. (id: 42661)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.